Compare Trulieve Cannabis Corp. with Similar Stocks
Stock DNA
Other Agricultural Products
CAD 3,104 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.03
-5.70%
1.90
Revenue and Profits:
Net Sales:
393 Million
(Quarterly Results - Mar 2026)
Net Profit:
5 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
84.04%
0%
84.04%
6 Months
96.35%
0%
96.35%
1 Year
210.98%
0%
210.98%
2 Years
28.1%
0%
28.1%
3 Years
201.68%
0%
201.68%
4 Years
-6.71%
0%
-6.71%
5 Years
-64.98%
0%
-64.98%
Trulieve Cannabis Corp. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
14.72%
EBIT Growth (5y)
2.10%
EBIT to Interest (avg)
3.83
Debt to EBITDA (avg)
1.07
Net Debt to Equity (avg)
0.14
Sales to Capital Employed (avg)
0.69
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.10%
ROCE (avg)
16.66%
ROE (avg)
3.00%
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
1.90
EV to EBIT
13.77
EV to EBITDA
6.61
EV to Capital Employed
1.93
EV to Sales
1.89
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
14.04%
ROE (Latest)
-5.70%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
Bearish
Bollinger Bands
Mildly Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
Shareholding Snapshot : Mar 2026
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 15 Foreign Institutions (0.1%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
393.30
408.80
-3.79%
Operating Profit (PBDIT) excl Other Income
118.80
90.70
30.98%
Interest
18.30
20.50
-10.73%
Exceptional Items
-9.80
-14.70
33.33%
Consolidate Net Profit
4.60
-62.70
107.34%
Operating Profit Margin (Excl OI)
149.60%
73.00%
7.66%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is -3.79% vs 3.00% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 107.34% vs -91.74% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
1,650.40
1,625.40
1.54%
Operating Profit (PBDIT) excl Other Income
464.20
369.70
25.56%
Interest
88.70
85.20
4.11%
Exceptional Items
-27.60
-17.70
-55.93%
Consolidate Net Profit
-163.00
-212.20
23.19%
Operating Profit Margin (Excl OI)
134.40%
87.20%
4.72%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 1.54% vs 6.65% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 23.19% vs 63.93% in Dec 2024
About Trulieve Cannabis Corp. 
Trulieve Cannabis Corp.
Other Agricultural Products
Trulieve Cannabis Corp is a Canada-based seed to sale licensed medical cannabis company. The Company cultivates and produces all of its products in-house and distributes those products to Trulieve branded stores (dispensaries), as well as directly to patients through home delivery. It also operates in California, Massachusetts and Connecticut. The Company offers a range of products, such as concentrates, flower, oil, capsules and tinctures. It operates a 35,000 square foot cultivation and processing facility in McKeesport, Pennsylvania. It operates three dispensaries, located in Pittsburgh-area locations and also offers medical marijuana relief solutions for Pennsylvanians certified with serious medical conditions. The Company's subsidiaries include PurePenn LLC, Pioneer Leasing & Consulting LLC and Keystone Relief Centers LLC.






